NEW YORK ( TheStreet) -- BioMarin Pharmaceuticals Inc (Nasdaq: BMRN) hit a new 52-week high Friday as it is currently trading at $34.74, above its previous 52-week high of $34.50 with 208,275 shares traded as of 10:01 a.m. ET. Average volume has been 1.1 million shares over the past 30 days. BioMarin has a market cap of $3.6 billion and is part of the health care sector and drugs industry. Shares are up 23.5% year to date as of the close of trading on Thursday. BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions. The company has a P/E ratio of 16.9, below the average drugs industry P/E ratio of 20.4 and below the S&P 500 P/E ratio of 17.7.
- Practice your BMRN trading strategies and win cash in our stock game.